期刊文献+

Determination of metabolite of nicergoline in human plasma by high-performance liquid chromatography and its application in pharmacokinetic studies 被引量:3

Determination of metabolite of nicergoline in human plasma by high-performance liquid chromatography and its application in pharmacokinetic studies
下载PDF
导出
摘要 A fast, simple and sensitive high performance liquid chromatographic (HPLC) method has been developed for determination of 10a-methoxy-6-methyl ergoline-8b-methanol (MDL, a main metabolite of nicergoline) in human plasma. One-step liquid–liquid extraction (LLE) with diethyl ether was employed as the sample preparation method. Tizanidine hydrochloride was selected as the internal standard (IS). Analysis was carried out on a Diamonsil ODS column (150 mm 4.6 mm, 5 mm) using acetonitrile–ammonium acetate (0.1 mol/L) (15/85, v/v) as mobile phase at detection wavelength of 224 nm. The calibration curves were linear over the range of 2.288–73.2 ng/mL with a lower limit of quantitation (LLOQ) of 2.288 ng/mL. The intra-and inter-day precision values were below 13% and the recoveries were from 74.47% to 83.20% at three quality control levels. The method herein described was successfully applied in a randomized crossover bioequivalence study of two different nicergoline preparations after administration of 30 mg in 20 healthy volunteers. A fast, simple and sensitive high performance liquid chromatographic (HPLC) method has been developed for determination of 10a-methoxy-6-methyl ergoline-8b-methanol (MDL, a main metabolite of nicergoline) in human plasma. One-step liquid–liquid extraction (LLE) with diethyl ether was employed as the sample preparation method. Tizanidine hydrochloride was selected as the internal standard (IS). Analysis was carried out on a Diamonsil ODS column (150 mm 4.6 mm, 5 mm) using acetonitrile–ammonium acetate (0.1 mol/L) (15/85, v/v) as mobile phase at detection wavelength of 224 nm. The calibration curves were linear over the range of 2.288–73.2 ng/mL with a lower limit of quantitation (LLOQ) of 2.288 ng/mL. The intra-and inter-day precision values were below 13% and the recoveries were from 74.47% to 83.20% at three quality control levels. The method herein described was successfully applied in a randomized crossover bioequivalence study of two different nicergoline preparations after administration of 30 mg in 20 healthy volunteers.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2012年第1期62-66,共5页 药物分析学报(英文版)
关键词 Nicergoline 10a-methoxy-6-methy- lergoline-8b-methanol (MDL) HPLC Plasma-drug concentration Bioequivalence study Nicergoline 10a-methoxy-6-methy- lergoline-8b-methanol (MDL) HPLC Plasma-drug concentration Bioequivalence study
  • 相关文献

参考文献6

二级参考文献17

  • 1张晓景.尼麦角林的药理作用及临床应用[J].西北药学杂志,2006,21(6):286-287. 被引量:23
  • 2仇丽颖,张丹.HPLC测定注射用尼麦角林的含量及其有关物质[J].华西药学杂志,2006,21(6):572-574. 被引量:5
  • 3仇丽颖,张丹.尼麦角林在大鼠体内的药代动力学研究[J].药物分析杂志,2007,27(3):328-331. 被引量:3
  • 4Ezan E, Delestre L, Legendre S, et al. Immunoassays for the detection of nicergoline and its metabolites in human plasma [ J ]. Pharm Biomed Anal,2001,25 : 123 - 130. 被引量:1
  • 5Yalcin G, Yuktas N. An efficient separation and method development for the quantifying of two basic impurities of Nicergoline by reversed-phase high performance liquid chromatography using ion-pairing counter ions [ J ]. J Pharm Biomed Anal, 2006, 42 ( 4 ) : 434 - 440. 被引量:1
  • 6Vairetti M, Ferrigno A, Canonico PL, et al. Nicergoline reverts hal operidol-induced loss of detoxifying-enzyme activity[J]. Eur J Pharmacol, 2004, 505 ( 1 - 3 ) : 121 - 125. 被引量:1
  • 7Caraci F, Chisari M, Frasca G, et al. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity [ J ]. Brain Res, 2005, 1 ( 14 ) :30 - 37. 被引量:1
  • 8Mizuno T, Kuno R, Nitta A, et al. Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes[J]. Brain Res, 2005, 1-2(20):78-85. 被引量:1
  • 9Carfagna N, Cavanus S, Damiani D, et al. Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged rats[ J]. Neurosci Lett, 1995, 197 : 195 - 198. 被引量:1
  • 10Waiter K. Using mass spectrometry for drug Metabolism Studies. Chapter S[M]. CRC Press: FL. USA. 2005. 被引量:1

共引文献4

同被引文献29

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部